XML 19 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Income Statement [Abstract]        
Revenue from product sales $ 68 $ 69 [1] $ 156 $ 113 [1]
Cost of sales 1,930 2,321 [1] 6,523 5,968 [1]
Gross loss (1,862) (2,252) [1] (6,367) (5,855) [1]
Selling, general and administrative expenses 2,902 2,632 [1] 7,719 9,594 [1]
Research and development expenses 8,357 426 [1] 10,753 1,294 [1]
Operating loss (13,121) (5,310) [1] (24,839) (16,743) [1]
Other income (expense)        
Warrant income (expense) 188 14,545 [1] (129) 17,192 [1]
Derivative revaluation income (expense)   1,894 [1]   (23) [1]
Interest expense   (140) [1]   (586) [1]
Extinguishment of debt       (4,421) [1]
(Loss) income from continuing operations before income taxes (12,933) 10,989 [1] (24,968) (4,581) [1]
Deferred tax benefit      [1]   2,500 [1]
(Loss) income from continuing operations (12,933) 10,989 [1] (24,968) (2,081) [1]
(Loss) income from discontinued operations, net of tax (4) 5 [1] (13) (1) [1]
Gain on sale of discontinued operations, net of tax   443 [1]   443 [1]
Net (loss) income (12,937) 11,437 [1] (24,981) (1,639) [1]
Net loss attributable to noncontrolling interest   (4) [1]   (24) [1]
Net (loss) income attributable to Fibrocell Science, Inc. common shareholders $ (12,937) $ 11,433 [1] $ (24,981) $ (1,663) [1]
Income (loss) from discontinued operations        
basic       [1]       [1]
diluted       [1]       [1]
Income from deferred tax benefit-basic and diluted       $ 0.64 [1]
Gain on sale of discontinued operations, net of tax-basic and diluted   $ 0.11 [1]   $ 0.11 [1]
Net (loss) income attributable to common shareholders per common share        
basic $ (0.48) $ 2.89 [1] $ (0.94) $ (0.43) [1]
diluted $ (0.48) $ (1.27) [1] $ (0.94) $ (0.43) [1]
Weighted average number of basic common shares outstanding 27,158,394 3,957,231 [1] 26,543,099 3,887,530 [1]
Weighted average number of diluted common shares outstanding 27,158,394 3,957,231 [1] 26,543,099 3,887,530 [1]
[1] Restated